ArticleSurgical case reports2026
Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm of the Esophagogastric Junction with Enteroblastic Differentiation and Morphologic-Immunophenotypic Discordance: A Case Report with Five-Year Disease-Free Survival.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs) of the esophagogastric junction (EGJ) are extremely rare and are generally associated with aggressive clinical behavior. Enteroblastic (fetal gut-like) differentiation at this anatomical site is uncommon and is regarded as a poor prognostic feature. In addition, discordance between tumor morphology and immunophenotype in such mixed tumors has rarely been documented, and its clinical significance remains unclear. We report an exceptionally rare case of an EGJ MiNEN with enteroblastic differentiation and morphologic-immunophenotypic discordance that achieved long-term disease-free survival after surgery alone. CASE PRESENTATION: An 81-year-old man presented with progressive dysphagia. Upper gastrointestinal endoscopy revealed a circumferential, ulcerated mass extending from the distal esophagus to the EGJ. Biopsy specimens suggested adenocarcinoma, and preoperative imaging demonstrated a localized EGJ tumor with suspected regional lymph node involvement. The patient underwent transhiatal distal esophagectomy with total gastrectomy, D2 lymphadenectomy, and Roux-en-Y reconstruction. Histopathological examination of the resected specimen demonstrated a MiNEN, with each component accounting for more than 30% of the tumor volume. The glandular component consisted of a well-to-moderately differentiated adenocarcinoma with clear-cell morphology and enteroblastic features, showing positivity for glypican-3 and SALL4 with focal alpha-fetoprotein expression. The neuroendocrine component was a high-grade tumor with a markedly elevated proliferative index. Notably, immunophenotypic overlap was observed between the two components, with expression of neuroendocrine markers in the glandular areas and enteroblastic markers in the neuroendocrine nests. Resection margins were tumor-free. No adjuvant therapy was administered because of the patient's advanced age and comorbidities. The patient remains alive and disease-free 5 years after surgery.
conclusionsThis case illustrates an exceptionally rare MiNEN of the EGJ with enteroblastic differentiation and morphologic-immunophenotypic discordance. Despite the presence of aggressive histologic features, long-term disease-free survival was achieved with surgical resection alone. This report highlights the importance of thorough histopathological and immunohistochemical evaluation for accurate diagnosis and suggests that curative surgery alone may provide durable disease control in carefully selected patients with localized disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.